Clinical trial for efficacy and safety three-microniddle device to the intradermal injection

Clinical trial for efficacy and safety three-microniddle device to the intradermal injection - Clinical trial of three-microniddle device

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013209

Enrollment

Registered

2014-02-21

Start date

2013-03-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial skin disease

Interventions

injector ordinarily used (31G) intradermal injection of 1% lidocaine which contained epinephrine/0.1ml three-microneedle device (31G) intradermal injection of 1% lidocaine which contained epinephrin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who need local anesthesia on the treatment for superficial skin disease

Exclusion criteria

Exclusion criteria: 1. minority under 20 years of age 2. Elderly person 60 years or older 3. Patient taking antithrombotic drug and/or anticoagulant

Design outcomes

Primary

Measure	Time frame
Evaluation of pain and anesthetic range	—

Countries

Japan

Contacts

Public ContactKoji Kanayama

University of Tokyo School of Medicine Plastic Surgery

kk0519@hotmail.co.jp03-5800-8949

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026